Exploring Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors for Organ Protection in COVID-19
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Exploring Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors for Organ Protection in COVID-19
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 9, Issue 7, Pages 2030
Publisher
MDPI AG
Online
2020-07-01
DOI
10.3390/jcm9072030
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The SGLT2 inhibitor empagliflozin reduces mortality and prevents progression in experimental pulmonary hypertension
- (2020) Biswajit Chowdhury et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis
- (2020) Eileen O’Meara et al. CANADIAN JOURNAL OF CARDIOLOGY
- The novel Chinese coronavirus (2019‐nCoV) infections: Challenges for fighting the storm
- (2020) Matteo Bassetti et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20–28 January 2020
- (2020) Jantien A Backer et al. Eurosurveillance
- COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission
- (2020) Jinyang Gu et al. GASTROENTEROLOGY
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- (2020) Zunyou Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Presumed Asymptomatic Carrier Transmission of COVID-19
- (2020) Yan Bai et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
- (2020) Hussin A. Rothan et al. JOURNAL OF AUTOIMMUNITY
- Updated understanding of the outbreak of 2019 novel coronavirus (2019‐nCoV) in Wuhan, China
- (2020) Weier Wang et al. JOURNAL OF MEDICAL VIROLOGY
- Cross‐species transmission of the newly identified coronavirus 2019‐nCoV
- (2020) Wei Ji et al. JOURNAL OF MEDICAL VIROLOGY
- Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle
- (2020) Hongzhou Lu et al. JOURNAL OF MEDICAL VIROLOGY
- Pneumonia of unknown aetiology in Wuhan, China: potential for international spread via commercial air travel
- (2020) Isaac I Bogoch et al. JOURNAL OF TRAVEL MEDICINE
- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
- (2020) Roujian Lu et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Asymptomatic cases in a family cluster with SARS-CoV-2 infection
- (2020) Xingfei Pan et al. LANCET INFECTIOUS DISEASES
- COVID-19 and the cardiovascular system
- (2020) Ying-Ying Zheng et al. Nature Reviews Cardiology
- Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
- (2020) Eva Schrezenmeier et al. Nature Reviews Rheumatology
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- First Case of 2019 Novel Coronavirus in the United States
- (2020) Michelle L. Holshue et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preventing a covid-19 pandemic
- (2020) John Watkins BMJ-British Medical Journal
- Influenza Polymerase Inhibitors: Mechanisms of Action and Resistance
- (2020) Emi Takashita Cold Spring Harbor Perspectives in Medicine
- Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19
- (2020) Markus Hoffmann et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
- (2020) Vanessa Monteil et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Identification of a novel coronavirus causing severe pneumonia in human
- (2020) Li-Li Ren et al. CHINESE MEDICAL JOURNAL
- Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis
- (2020) Brandon Michael Henry et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19
- (2020) Jie Ma et al. CLINICAL IMMUNOLOGY
- Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China
- (2020) Bo Li et al. Clinical Research in Cardiology
- Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?
- (2020) Daniel Batlle et al. CLINICAL SCIENCE
- Erratum. Predicting 10-Year Risk of End-Organ Complications of Type 2 Diabetes With and Without Metabolic Surgery: A Machine Learning Approach. Diabetes Care 2020;43:852–859
- (2020) Ali Aminian et al. DIABETES CARE
- Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study
- (2020) Rong-Hui Du et al. EUROPEAN RESPIRATORY JOURNAL
- Considerations for Drug Interactions on QTc Interval in Exploratory COVID-19 Treatment
- (2020) Dan M. Roden et al. HEART RHYTHM
- A Review of SARS-CoV-2 and the Ongoing Clinical Trials
- (2020) Yung-Fang Tu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection
- (2020) Brandon Michael Henry et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes
- (2020) Mark C. Petrie et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
- (2020) Chenguang Shen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)
- (2020) James M. Sanders et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy
- (2020) Giacomo Grasselli et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency
- (2020) Calvin J. Gordon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19
- (2020) Zhen Zhu et al. JOURNAL OF INFECTION
- Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study
- (2020) Lisi Deng et al. JOURNAL OF INFECTION
- Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19)
- (2020) Dae-Gyun Ahn et al. JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY
- COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up
- (2020) Behnood Bikdeli et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Role of Impaired Nutrient and Oxygen Deprivation Signaling and Deficient Autophagic Flux in Diabetic CKD Development: Implications for Understanding the Effects of Sodium-Glucose Cotransporter 2-Inhibitors
- (2020) Milton Packer JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Kidney disease is associated with in-hospital death of patients with COVID-19
- (2020) Yichun Cheng et al. KIDNEY INTERNATIONAL
- Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?
- (2020) Andrew I Ritchie et al. LANCET
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
- (2020) Yeming Wang et al. LANCET
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- Real estimates of mortality following COVID-19 infection
- (2020) David Baud et al. LANCET INFECTIOUS DISEASES
- Chloroquine paradox may cause more damage than help fight COVID-19
- (2020) Anuj Sharma MICROBES AND INFECTION
- Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19
- (2020) Giuseppe Mancia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19
- (2020) Mandeep R. Mehra et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
- (2020) Muthiah Vaduganathan et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure
- (2020) Luca Spiezia et al. THROMBOSIS AND HAEMOSTASIS
- Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases
- (2020) Cynthia Magro et al. Translational Research
- Coronavirus in pregnancy and delivery: rapid review
- (2020) E. Mullins et al. ULTRASOUND IN OBSTETRICS & GYNECOLOGY
- Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis
- (2020) Alfonso J. Rodriguez-Morales et al. Travel Medicine and Infectious Disease
- Is ethnicity linked to incidence or outcomes of covid-19?
- (2020) Kamlesh Khunti et al. BMJ-British Medical Journal
- SGLT-2 inhibitors for COVID-19 — A miracle waiting to happen or just another beat around the bush?
- (2020) Subhankar Chatterjee Primary Care Diabetes
- Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base
- (2020) Fabio S Taccone et al. Lancet Respiratory Medicine
- Lack of Efficacy of SGLT2-i in Severe Pneumonia Related to Novel Coronavirus (nCoV) Infection: No Little Help from Our Friends
- (2020) Antonio Carlo Bossi et al. Diabetes Therapy
- Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases
- (2020) Cynthia Liu et al. ACS Central Science
- Sodium–Glucose Cotransporter 2 Inhibitors and Kidney Outcomes: True Renoprotection, Loss of Muscle Mass or Both?
- (2020) Adrian Post et al. Journal of Clinical Medicine
- Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
- (2020) Yadi Zhou et al. Cell Discovery
- The pathogenesis and treatment of the `Cytokine Storm' in COVID-19
- (2020) Qing Ye et al. JOURNAL OF INFECTION
- Hepatitis C – New drugs and treatment prospects
- (2019) Marianna Zając et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA
- (2019) Pantelis Sarafidis et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- The effect of SGLT-2 inhibitors on albuminuria and proteinuria in diabetes mellitus
- (2019) Alexia Piperidou et al. JOURNAL OF HYPERTENSION
- Euglycemic diabetic ketoacidosis
- (2019) Leonid Barski et al. European Journal of Internal Medicine
- PGC‐1α deficiency causes spontaneous kidney inflammation and increases the severity of nephrotoxic AKI
- (2019) Miguel Fontecha‐Barriuso et al. JOURNAL OF PATHOLOGY
- Therapeutic strategies to target the Ebola virus life cycle
- (2019) Thomas Hoenen et al. NATURE REVIEWS MICROBIOLOGY
- The New Era for Reno-Cardiovascular Treatment in Type 2 Diabetes
- (2019) Clara García-Carro et al. Journal of Clinical Medicine
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- SGLT2 Inhibitors: A Review of Their Antidiabetic and Cardioprotective Effects
- (2019) Anastasios Tentolouris et al. International Journal of Environmental Research and Public Health
- The beneficial actions of SGLT-2 inhibitors beyond management of hyperglycemia
- (2019) Charalampos Loutradis et al. CURRENT MEDICINAL CHEMISTRY
- A phase 1/2 trial to evaluate the pharmacokinetics, safety, and efficacy of NI-03 in patients with chronic pancreatitis: study protocol for a randomized controlled trial on the assessment of camostat treatment in chronic pancreatitis (TACTIC)
- (2019) Mitchell L. Ramsey et al. Trials
- European Society of Cardiology/Heart Failure Association position paper on the role and safety of new glucose‐lowering drugs in patients with heart failure
- (2019) Petar M. Seferović et al. EUROPEAN JOURNAL OF HEART FAILURE
- Ketogenesis-generated β-hydroxybutyrate is an epigenetic regulator of CD8+ T-cell memory development
- (2019) Huafeng Zhang et al. NATURE CELL BIOLOGY
- Sodium-glucose cotransporter 2 inhibition: towards an indication to treat diabetic kidney disease
- (2019) Jose Luis Górriz et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Exploration of the clinical benefits of sodium glucose co-transporter 2 inhibitors in diabetic patients with concomitant heart failure
- (2018) Atsushi Tanaka et al. Cardiovascular Diabetology
- MECHANISMS IN ENDOCRINOLOGY: SGLT2 inhibitors: clinical benefits by restoration of normal diurnal metabolism?
- (2018) Russell L Esterline et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Safety and efficacy of the CD95-ligand inhibitor asunercept in transfusion-dependent patients with low and intermediate risk MDS
- (2018) Tobias Boch et al. LEUKEMIA RESEARCH
- Arbidol (Umifenovir): A Broad-Spectrum Antiviral Drug That Inhibits Medically Important Arthropod-Borne Flaviviruses
- (2018) Jan Haviernik et al. Viruses-Basel
- Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials
- (2018) Vlado Perkovic et al. Lancet Diabetes & Endocrinology
- Weight loss associated with sodium-glucose cotransporter-2 inhibition: a review of evidence and underlying mechanisms
- (2018) P. C. Lee et al. Obesity Reviews
- SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- (2018) Thomas A Zelniker et al. LANCET
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
- (2017) Yousuke FURUTA et al. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Comparative efficacy and safety of second-line antiretroviral therapy for treatment of HIV/AIDS: a systematic review and network meta-analysis
- (2017) Steve Kanters et al. Lancet HIV
- SGLT2 Inhibitor–associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and Diagnosis
- (2016) Ronald M. Goldenberg et al. CLINICAL THERAPEUTICS
- Sodium glucose cotransporter 2 inhibition in the diabetic kidney
- (2016) Aleksandra Novikov et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Sodium-glucose cotransporter-2 inhibition for the reduction of cardiovascular events in high-risk patients with diabetes mellitus
- (2016) Nikolaus Marx et al. EUROPEAN HEART JOURNAL
- The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses
- (2016) Eve-Isabelle Pécheur et al. JOURNAL OF VIROLOGY
- The inflammatory cytokine TWEAK decreases PGC-1α expression and mitochondrial function in acute kidney injury
- (2016) Olga Ruiz-Andres et al. KIDNEY INTERNATIONAL
- SGLT inhibitors attenuate NO-dependent vascular relaxation in the pulmonary artery but not in the coronary artery
- (2015) Ying Han et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program
- (2015) Ngozi Erondu et al. DIABETES CARE
- Sodium–glucose cotransporter-2 inhibitors and blood pressure decrease
- (2015) Konstantinos P. Imprialos et al. JOURNAL OF HYPERTENSION
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus
- (2013) David Z.I. Cherney et al. CIRCULATION
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started